Like you had posted previously on this type of project, ie it doesn't move the needle much for big pharma or biotech. Why should this be surprising that there is no interest from the big companies in this case? I read that big pharma would only be interested in a few years if Covid becomes a recurring disease.
Market Data 
Markets 
AI
